ACA
Avoro Capital Advisors Portfolio holdings
AUM
$5.71B
1-Year Return
11.37%
This Quarter Return
-10.89%
1 Year Return
+11.37%
3 Year Return
+255.37%
5 Year Return
+558.9%
10 Year Return
+18,722.72%
AUM
$378M
AUM Growth
+$15.8M
(+4.4%)
Cap. Flow
+$76.1M
Cap. Flow
% of AUM
20.12%
Top 10 Holdings %
Top 10 Hldgs %
70.94%
Holding
39
New
6
Increased
16
Reduced
3
Closed
7
Top Buys
Top Sells
| 1 |
Celldex Therapeutics
CLDX
|
$8.89M |
| 2 |
Tonix Pharmaceuticals
TNXP
|
$6.78M |
| 3 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$5.67M |
| 4 |
BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
|
$5.58M |
| 5 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$5.04M |
Sector Composition
| 1 | Healthcare | 91.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Tonix Pharmaceuticals
TNXP
$233M
| – | – |
0
| – | -$6.78M |
|
|
SCPX
27
DELISTED
Scorpius Holdings, Inc.
SCPX
| $1.58M | 0.41% |
1
| – | – |
|
|
CLLS
28
Cellectis
CLLS
$269M
| $923K | 0.24% |
35,000
+5,000
| +17% | +$132K |
|
29
Gyre Therapeutics
GYRE
$698M
| $391K | 0.1% |
746
| – | – |
|
|
ADAP
30
Adaptimmune Therapeutics
ADAP
$10.9M
| – | – |
-183,900
| Closed | -$3.37M |
|
|
AVDL
31
Avadel Pharmaceuticals
AVDL
$1.53B
| – | – |
-267,747
| Closed | -$5.67M |
|
32
Biogen
BIIB
$20.6B
| – | – |
-4,500
| Closed | -$1.82M |
|
|
33
Celldex Therapeutics
CLDX
$1.52B
| – | – |
-23,490
| Closed | -$8.89M |
|
34
Heron Therapeutics
HRTX
$201M
| – | – |
-150,000
| Closed | -$4.67M |
|
35
iShares Russell 2000 ETF
IWM
$67.8B
| – | – |
0
| – | – |
|
36
SPDR NYSE Technology ETF
XNTK
$1.26B
| – | – |
0
| – | – |
|
|
BLCM
37
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| – | – |
-26,252
| Closed | -$5.58M |
|
|
KITE
38
DELISTED
Kite Pharma, Inc.
KITE
| – | – |
0
| – | – |
|
|
RCPT
39
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| – | – |
-26,500
| Closed | -$5.04M |
|